Innovation Pharmaceuticals Inc (IPIX)

[Rdunn88]

19 subjects used for OM interim analysis? They should have close to 30 completed now which includes the evaluation period. Makes no sense for OM and not a pandemic situation.

presented below is information on Cellceutix’s clinical trial of Brilacidin for OM, including preliminary Interim Analysis of 19 patients (9 administered Brilacidin; 10 administered placebo) who have reached or passed the planned visit at the end of 5 weeks on study, and received a cumulative radiation dose of at least 55 Gy.


http://www.ipharminc.com/new-press-release/2017/3/26/cellceutix-reports-very-encouraging-interim-analysis-of-phase-2-drug-candidate-brilacidin-for-severe-oral-mucositis-om-in-head-and-neck-cancer-patients-high-potential-for-preventative--cyml9